AIM ImmunoTech Inc.

AIM ImmunoTech Inc.verified

AIM

Price:

$0.2101

Market Cap:

$13.38M

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of nat...[Read more]

Industry

Biotechnology

IPO Date

1996-07-12

Stock Exchange

AMEX

Ticker

AIM

The Enterprise Value as of November 2024 (TTM) for AIM ImmunoTech Inc. (AIM) is 15.87M

According to AIM ImmunoTech Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.87M. This represents a change of -19.42% compared to the average of 19.70M of the last 4 quarters.

AIM ImmunoTech Inc. (AIM) Historical Enterprise Value (quarterly & annually)

How has AIM Enterprise Value performed in the past?

The mean historical Enterprise Value of AIM ImmunoTech Inc. over the last ten years is 14.31M. The current 15.87M Enterprise Value has changed 10.99% with respect to the historical average. Over the past ten years (40 quarters), AIM's Enterprise Value was at its highest in in the June 2021 quarter at 61.86M. The Enterprise Value was at its lowest in in the December 2022 quarter at -11218510.88.

Quarterly (TTM)
Annual

Average

14.31M

Median

13.11M

Minimum

-11230050.87

Maximum

44.94M

AIM ImmunoTech Inc. (AIM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AIM ImmunoTech Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 201.56%

Maximum Annual Enterprise Value = 44.94M

Minimum Annual Increase = -248.28%

Minimum Annual Enterprise Value = -11230050.87

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202316.65M-248.28%
2022-11230050.87-196.74%
202111.61M-44.14%
202020.78M201.56%
20196.89M-49.25%
201813.58M29.83%
201710.46M-17.29%
201612.65M-24.62%
201516.78M-62.66%
201444.94M1.14%

AIM ImmunoTech Inc. (AIM) Average Enterprise Value

How has AIM Enterprise Value performed in the past?

The current Enterprise Value of AIM ImmunoTech Inc. (AIM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

5.68M

5-year avg

8.94M

10-year avg

14.31M

AIM ImmunoTech Inc. (AIM) Enterprise Value vs. Peers

How is AIM’s Enterprise Value compared to its peers?

AIM ImmunoTech Inc.’s Enterprise Value is greater than Aptorum Group Limited (5.11M), greater than Applied Molecular Transport Inc. (-5743713.00), greater than Fresh Tracks Therapeutics, Inc. (-6567217.00), greater than BioCardia, Inc. (6.48M), greater than Virax Biolabs Group Limited (5.36M), greater than Blue Water Vaccines, Inc. (8.67M), greater than Revelation Biosciences, Inc. (-3300245.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Kiora Pharmaceuticals, Inc. (4.55M), greater than Forte Biosciences, Inc. (7.03M), less than Cellectar Biosciences, Inc. (31.46M), greater than Diffusion Pharmaceuticals Inc. (-1447403.00), greater than Tonix Pharmaceuticals Holding Corp. (13.15M), greater than Onconova Therapeutics, Inc. (4.51M), less than Jaguar Health, Inc. (33.27M), less than Vaxart, Inc. (132.65M), less than VBI Vaccines Inc. (39.99M), greater than Pulmatrix, Inc. (11.57M), less than Capricor Therapeutics, Inc. (2.43B), less than Akari Therapeutics, Plc (17.47M), less than Soleno Therapeutics, Inc. (2.45B),

Build a custom stock screener for AIM ImmunoTech Inc. (AIM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AIM ImmunoTech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AIM ImmunoTech Inc. (AIM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AIM ImmunoTech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AIM ImmunoTech Inc.'s Enterprise Value?

What is the highest Enterprise Value for AIM ImmunoTech Inc. (AIM)?

What is the 3-year average Enterprise Value for AIM ImmunoTech Inc. (AIM)?

What is the 5-year average Enterprise Value for AIM ImmunoTech Inc. (AIM)?

How does the current Enterprise Value for AIM ImmunoTech Inc. (AIM) compare to its historical average?